-
T646328-5mgTL8-506 is a specific TLR8 agonist with an EC 50 of 30 nM. TL8-506 can be used for the research of tuberculosis and autoimmune diseases.Form:Solid
-
T647828-10mgTLR7 agonist 1 is a potent, selective and oral TLR7 agonist with an IC 50 of 90 nM.Form:SolidIC50& Target:TLR7 90 nM (IC 50 )
-
T647828-25mgTLR7 agonist 1 is a potent, selective and oral TLR7 agonist with an IC 50 of 90 nM.Form:SolidIC50& Target:TLR7 90 nM (IC 50 )
-
T647828-5mgTLR7 agonist 1 is a potent, selective and oral TLR7 agonist with an IC 50 of 90 nM.Form:SolidIC50& Target:TLR7 90 nM (IC 50 )
-
T655190-1mlTLR7 agonist 1 is a potent, selective and oral TLR7 agonist with an IC 50 of 90 nM.IC50& Target:TLR7 90 nM (IC 50 )
-
T648817-10mgTLR7 agonist 2 is a potent and selective Toll-like Receptor 7 ( TLR7 ) agonist with a LEC of 0.4 μM.In VitroTLR7 agonist 2 is a potent and selective Toll-like Receptor 7 (TLR7) agonist with a lowest effective concentration (LEC) of 0.4 μM in HEK293
-
T648817-1mgTLR7 agonist 2 is a potent and selective Toll-like Receptor 7 ( TLR7 ) agonist with a LEC of 0.4 μM.In VitroTLR7 agonist 2 is a potent and selective Toll-like Receptor 7 (TLR7) agonist with a lowest effective concentration (LEC) of 0.4 μM in HEK293
-
T648817-5mgTLR7 agonist 2 is a potent and selective Toll-like Receptor 7 ( TLR7 ) agonist with a LEC of 0.4 μM.In VitroTLR7 agonist 2 is a potent and selective Toll-like Receptor 7 (TLR7) agonist with a lowest effective concentration (LEC) of 0.4 μM in HEK293
-
T655584-1mlTLR7 agonist 2 is a potent and selective Toll-like Receptor 7 ( TLR7 ) agonist with a LEC of 0.4 μM.In VitroTLR7 agonist 2 is a potent and selective Toll-like Receptor 7 (TLR7) agonist with a lowest effective concentration (LEC) of 0.4 μM in HEK293
-
T648789-100mgTLR7 agonist 3 (Compound 2) is a potent agonist of toll-like receptor 7 (TLR7). TLR7 has an important role in immune activation processes and represents an emerging agent discovery target for the development of immunomodulatorsForm:SolidIC50&
-
T648789-10mgTLR7 agonist 3 (Compound 2) is a potent agonist of toll-like receptor 7 (TLR7). TLR7 has an important role in immune activation processes and represents an emerging agent discovery target for the development of immunomodulatorsForm:SolidIC50&
-
T648789-25mgTLR7 agonist 3 (Compound 2) is a potent agonist of toll-like receptor 7 (TLR7). TLR7 has an important role in immune activation processes and represents an emerging agent discovery target for the development of immunomodulatorsForm:SolidIC50&